cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently prevent infectious diseases and are safe in animal models and humans. In this study, we fabricated a multivalent influenza mRNA lipid nanoparticle (LNP) vaccine with mRNAs of hemagglutinins from influenza H1...
Saved in:
Main Authors: | Wandi Zhu (Author), Lai Wei (Author), Chunhong Dong (Author), Ye Wang (Author), Joo Kim (Author), Yao Ma (Author), Gilbert X. Gonzalez (Author), Bao-Zhong Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021) -
Compound C Reducing Interferon Expression by Inhibiting cGAMP Accumulation
by: Junzhong Lai, et al.
Published: (2020) -
Parenteral immunization with a cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) adjuvanted Helicobacter pylori vaccine induces protective immunity against H. pylori infection in mice
by: Jing Chen, et al.
Published: (2020) -
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
by: Tatyana V. Korneenko, et al.
Published: (2023) -
Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations
by: Dylan A. Hendy, et al.
Published: (2024)